These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31514792)

  • 1. Risk stratification of systemic reactions to subcutaneous immunotherapy: A retrospective study.
    Sani S; Gupta R; Fonacier L; Aquino M
    Allergy Asthma Proc; 2019 Sep; 40(5):338-342. PubMed ID: 31514792
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analysis of adverse reactions induced by subcutaneous immunotherapy against dust mite allergy in 234 cases with allergic rhinitis and asthma].
    Li MR; Wang XN; Jiang HD; Wang QY; Li YC; Lin J; Jin K; Zhang HL; Li CC
    Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):726-31. PubMed ID: 23302557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Observation and analysis of systemic reactions to house dust mite subcutaneous immunotherapy in 362 patients with allergic rhinitis].
    Xue JR; Ma J; Qiu CY; Hu ZB; Jiang X; Pan M; Lu MP; Cheng L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 May; 55(5):445-451. PubMed ID: 32842357
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccination during concurrent subcutaneous immunotherapy: safety of simultaneous application.
    Ullrich D; Ullrich K; Mussler S; Thum-Oltmer S
    Eur Ann Allergy Clin Immunol; 2015 Jan; 47(1):10-4. PubMed ID: 25599553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Reactions in Pediatric Patients Receiving Standardized Allergen Subcutaneous Immunotherapy with and without Seasonal Dose Adjustment.
    Albuhairi S; Sare T; Lakin P; El Khoury K; Crestani E; Schneider LC; Anzaldi R; Patterson A; Rachid R
    J Allergy Clin Immunol Pract; 2018; 6(5):1711-1716.e4. PubMed ID: 29339129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions.
    Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI
    J Allergy Clin Immunol Pract; 2014; 2(2):161-7. PubMed ID: 24607043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local and systemic reactions to subcutaneous allergen immunotherapy: Ten years' experience in a pediatric clinic.
    Nacaroglu HT; Erdem SB; Sumer O; Karaman S; Unsal Karkıner CS; Asilsoy S; Gunay I; Can D
    Ann Allergy Asthma Immunol; 2016 Apr; 116(4):349-53. PubMed ID: 26905639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of risk factors for systemic adverse reactions to SCIT with natural depot allergen extracts: a retrospective study.
    Asero R
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):211-7. PubMed ID: 26549339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of systemic allergic reactions to allergen immunotherapy in a pediatric allergy clinic in Turkey.
    Bahceci Erdem S; Nacaroglu HT; Karaman S; Unsal Karkıner CS; Gunay I; Dogan D; Asilsoy S; Altınoz S; Can D
    Int J Pediatr Otorhinolaryngol; 2016 May; 84():55-60. PubMed ID: 27063754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine.
    Phillips JF; Lockey RF; Fox RW; Ledford DK; Glaum MC
    Allergy Asthma Proc; 2011; 32(4):288-94. PubMed ID: 21781404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are large local reactions a marker for systemic reactions to subcutaneous immunotherapy in children?
    Simsek IE; Aydogan M
    Asian Pac J Allergy Immunol; 2022 Mar; 40(1):75-80. PubMed ID: 34246207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic reactions to subcutaneous immunotherapy: Effects of dosing and aeroallergen content.
    Mustafa SS; Bingemann T; Blue H; Conn K; Hanley T; Ramsey A
    Ann Allergy Asthma Immunol; 2019 Sep; 123(3):284-287. PubMed ID: 31276805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey.
    Kartal O; Gulec M; Caliskaner Z; Musabak U; Sener O
    Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):280-6. PubMed ID: 25858053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of subcutaneous immunotherapy in patients with severe asthma.
    Chow TG; Palka JM; Stone B; Trojan T; Epstein TG; Khan DA
    Ann Allergy Asthma Immunol; 2022 Nov; 129(5):585-591.e3. PubMed ID: 35998846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAAAI/ACAAI Subcutaneous Immunotherapy Surveillance Study (2013-2017): Fatalities, Infections, Delayed Reactions, and Use of Epinephrine Autoinjectors.
    Epstein TG; Liss GM; Berendts KM; Bernstein DI
    J Allergy Clin Immunol Pract; 2019; 7(6):1996-2003.e1. PubMed ID: 30776526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment.
    Calderón MA; Vidal C; Rodríguez Del Río P; Just J; Pfaar O; Tabar AI; Sánchez-Machín I; Bubel P; Borja J; Eberle P; Reiber R; Bouvier M; Lepelliez A; Klimek L; Demoly P;
    Allergy; 2017 Mar; 72(3):462-472. PubMed ID: 27718250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic reaction rates with omalizumab, subcutaneous immunotherapy, and combination therapy in children with allergic asthma.
    Har D; Lee MJ
    Allergy Asthma Proc; 2019 Jan; 40(1):35-40. PubMed ID: 30582494
    [No Abstract]   [Full Text] [Related]  

  • 18. [Risk factors of systemic allergic reactions caused by subcutaneous allergen immunotherapy].
    Li LS; Guan K; Yin J; Wang LL; Zhi YX; Sun JL; Li H; Wen LP; Tang R; Gu JQ; Wang ZX; Cui L; Xu YY; Bian SN
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Dec; 57(12):1972-1977. PubMed ID: 38186144
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of allergen immunotherapy in North America from 2008-2017: Lessons learned from the ACAAI/AAAAI National Surveillance Study of adverse reactions to allergen immunotherapy.
    Bernstein DI; Epstein TEG
    Allergy Asthma Proc; 2020 Mar; 41(2):108-111. PubMed ID: 32122446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy: National surveillance study on allergen immunotherapy (2008-2013).
    Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI
    Ann Allergy Asthma Immunol; 2016 Apr; 116(4):354-359.e2. PubMed ID: 26948485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.